Thrombolytic Therapy (Tissue Plasminogen Activator - TPA)
Alternate Names : Activase Thrombolytic Agent, Alteplase, Clot-Dissolving Agents, Reperfusion Therapy, Reteplase, Tenecteplase, TPA
 See all Pictures & Images
Risks
Hemorrhage or bleeding is the most common risk associated with the administration of tPA therapy. Bleeding which is mostly minor, such as gum or nose bleeding, can occur in approximately 25% of people, while bleeding into the brain occurs approximately 1% of the time. This is true for both stroke and heart attack patients.
|
